Fairley, J. A.

Dr. Fairley, J. A. is a researcher at the German Cancer Research Center (DKFZ) specializing in liquid biopsy and circulating tumor DNA (ctDNA) analysis. As a contributor to the 2023 European Liquid Biopsy Society ctDNA Workshop, Dr. Fairley helped develop consensus guidelines for reporting molecular test results from cell-free DNA analyses.

Dr. Fairley's research interests focus on liquid biopsy, molecular diagnostics, and cancer biomarkers, with particular emphasis on standardizing the communication of liquid biopsy findings between diagnostic laboratories and oncology teams. Their work addresses the complexities of ctDNA testing compared to conventional tissue-based NGS.

The recent publication in EBioMedicine (2025) demonstrates Dr. Fairley's involvement in developing practical guidelines based on real-world experiences from a multidisciplinary group of 44 experts across molecular diagnostics laboratories, oncology, and pathology departments.

Dr. Fairley's work supports non-invasive approaches to cancer diagnostics that can benefit patients who lack suitable tumor specimens or are ineligible for biopsy procedures, enabling more personalized treatment selection through predictive biomarker testing.